Association Between Lifestyle and Hypertriglyceridemic Waist Phenotype in the PREDIMED-Plus Study

© 2020 The Obesity Society..

OBJECTIVE: The hypertriglyceridemic waist (HTGW) phenotype is characterized by abdominal obesity and high levels of triglycerides. In a cross-sectional assessment of PREDIMED-Plus trial participants at baseline, HTGW phenotype prevalence was evaluated, associated risk factors were analyzed, and the lifestyle of individuals with metabolic syndrome and HTGW was examined.

METHODS: A total of 6,874 individuals aged 55 to 75 with BMI ≥ 27 and < 40 kg/m2 were included and classified by presence (HTGW+ ) or absence (HTGW- ) of HTGW (waist circumference: men ≥ 102 cm, women ≥ 88 cm; fasting plasma triglycerides ≥ 150 mg/dL). Analytical parameters and lifestyle (energy intake and expenditure) were analyzed.

RESULTS: A total of 38.2% of the sample met HTGW+ criteria. HTGW+ individuals tended to be younger, have a greater degree of obesity, be sedentary, and be tobacco users. They had higher peripheral glucose, total cholesterol, and low-density lipoprotein cholesterol levels; had lower high-density lipoprotein cholesterol levels; and had increased prevalence of type 2 diabetes mellitus. Mediterranean diet (MedDiet) adherence and physical activity were greater in HTGW- patients. Age, BMI, tobacco use, total energy expenditure, hypertension, type 2 diabetes mellitus, and MedDiet adherence were associated with HTGW+.

CONCLUSIONS: HTGW is a highly prevalent phenotype in this population associated with younger age, higher BMI, tobacco use, and decreased MedDiet adherence. HTGW- individuals were more physically active with greater total physical activity, and fewer had hypertension.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

Obesity (Silver Spring, Md.) - 28(2020), 3 vom: 23. März, Seite 537-543

Sprache:

Englisch

Beteiligte Personen:

Fernández-García, José Carlos [VerfasserIn]
Muñoz-Garach, Araceli [VerfasserIn]
Martínez-González, Miguel Ángel [VerfasserIn]
Salas-Salvado, Jordi [VerfasserIn]
Corella, Dolores [VerfasserIn]
Hernáez, Álvaro [VerfasserIn]
Romaguera, Dora [VerfasserIn]
Vioque, Jesús [VerfasserIn]
Alonso-Gómez, Ángel M [VerfasserIn]
Wärnberg, Julia [VerfasserIn]
Martínez, J Alfredo [VerfasserIn]
Serra-Majem, Luís [VerfasserIn]
Estruch, Ramón [VerfasserIn]
Lapetra, José [VerfasserIn]
Pintó, Xavier [VerfasserIn]
Tur, Josep A [VerfasserIn]
Garcia-Rios, Antonio [VerfasserIn]
García Molina, Laura [VerfasserIn]
Gaforio, José Juan [VerfasserIn]
Matía-Martín, Pilar [VerfasserIn]
Daimiel, Lidia [VerfasserIn]
Martín Sánchez, Vicente [VerfasserIn]
Vidal, Josep [VerfasserIn]
Prieto, Lucia [VerfasserIn]
Ros, Emilio [VerfasserIn]
Goñi, Nuria [VerfasserIn]
Babio, Nancy [VerfasserIn]
Ortega-Azorin, Carolina [VerfasserIn]
Castañer, Olga [VerfasserIn]
Konieczna, Jadwiga [VerfasserIn]
Notario Barandiaran, Leyre [VerfasserIn]
Vaquero-Luna, Jessica [VerfasserIn]
Benavente-Marín, Juan Carlos [VerfasserIn]
Zulet, M Angeles [VerfasserIn]
Sanchez-Villegas, Almudena [VerfasserIn]
Sacanella, Emilio [VerfasserIn]
Gómez Huelgas, Ricardo [VerfasserIn]
Miró-Moriano, Leticia [VerfasserIn]
Gimenez-Gracia, Mariano [VerfasserIn]
Julibert, Alicia [VerfasserIn]
Razquin, Cristina [VerfasserIn]
Basora, Josep [VerfasserIn]
Portolés, Olga [VerfasserIn]
Goday, Albert [VerfasserIn]
Galmés-Panadés, Aina M [VerfasserIn]
López-García, Carmen M [VerfasserIn]
Moreno-Rodriguez, Anai [VerfasserIn]
Toledo, Estefanía [VerfasserIn]
Díaz-López, Andrés [VerfasserIn]
Fitó, Montserrat [VerfasserIn]
Tinahones, Francisco J [VerfasserIn]
Bernal-López, M Rosa [VerfasserIn]
PREDIMED-Plus Investigators [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Triglycerides

Anmerkungen:

Date Completed 28.08.2020

Date Revised 28.08.2020

published: Print

Citation Status MEDLINE

doi:

10.1002/oby.22728

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306833581